|
Characteristic/Variable
|
Non-T2D group (n = 15)
|
T2D group (n = 10)
|
p-value
|
|---|
|
Total anti-HTN drugs*
|
3.3 ± 0.5 [3.1 - 3.6]
|
4.1 ± 0.7 [3.6 - 4.6]
|
0.02
|
|
Thiazide diuretic
|
100% (15)
|
100% (10)
|
-
|
|
Aldosterone receptor inhibitor
|
26.6% (4)
|
50% (5)
|
0.40
|
|
Angiotensin converting enzyme inhibitor
|
66.6% (10)
|
50% (5)
|
0.68
|
|
Angiotensin receptor blocker
|
40% (6)
|
70% (7)
|
0.23
|
|
Calcium channel blocker
|
86.6% (13)
|
100% (10)
|
0.50
|
|
Centrally acting anti-hypertensive drug
|
6.6% (1)
|
40% (4)
|
0.12
|
- The values are expressed as means ± standard deviation; [95% confidence interval]; (*) Statistical significance (p < 0.05). Non-T2D: non type 2 diabetes resistant hypertension; T2D: type 2 diabetes resistant hypertension.
